Merrill Lynch Downgraded Credit Suisse (CS) to Sell
More News related to CS
- Express Scripts to Present at Credit Suisse Healthcare Conference
- Zimmer Holdings to Present at Credit Suisse 18th Annual Global Healthcare Conference
- BioMarin to Present at the Credit Suisse Healthcare Conference
- Notable Analyst Rating Changes 11/02: MOT, UFS, GNW, EL, JWN, WY, RCL, CS Upgraded; RIMM, PALM, CMCSA, ERJ, GERN Downgraded
- Citi Upgrades Credit Suisse (CS) to Buy
Merrill Lynch downgraded Credit Suisse (NYSE: CS) from Neutral to Sell, citing valuation and the potential for more write-downs.
Credit Suisse Group operates as a financial services company worldwide. It operates through three segments: Private Banking, Investment Banking, and Asset Management.
Related Categories
DowngradesStocks Mentioned
+1.49Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
